C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Abstract To evaluate the prognostic value of biomarkers from peripheral blood obtained as routine laboratory assessment for overall survival in a cohort of stage III non-small cell lung cancer (NSCLC) patients treated with definitive radiochemotherapy at a high-volume cancer center. Seven blood biom...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Cedric Richlitzki, Marcel Wiesweg, Martin Metzenmacher, Nika Guberina, Christoph Pöttgen, Hubertus Hautzel, Wilfried E. E. Eberhardt, Kaid Darwiche, Dirk Theegarten, Clemens Aigner, Servet Bölükbas, Martin Schuler, Martin Stuschke, Maja Guberina
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Nature Portfolio 2024-06-01
Serie:	Scientific Reports
Ämnen:	C-reactive protein (CRP) Stage III non-small cell lung cancer (NSCLC) Definitive radiochemotherapy Laboratory values Overall survival ESPATUE trial
Länkar:	https://doi.org/10.1038/s41598-024-64302-2
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!